DIAGNOSTIC REPORT

MC -5767

PATIENT NAME : SUNDARAM ANNASWAMY REF. DOCTOR : DR. Srinivasa Phanidhar Munigoti
CODE/NAME & ADDRESS : C000027810 ACCESSION NO : 0081WH000271 AGE/SEX : 83 Years Male
FHSL BG ROAD - OPD PATIENT ID : FH.4937401 DRAWN : 01/08/2023 10:30:00
SURVEY NO. 154/9, OPP. IIM-B,BANNERGHATTA
CLIENT PATIENT ID: UID:4937401 RECEIVED : 01/08/2023 10:30:27
ROAD,
ABHA NO : REPORTED : 01/08/2023 11:50:56
BANGALORE 560020
80-66214444

CLINICAL INFORMATION :

UID:4937401 REQNO-6146834
OPD-OPD
BILLNO-111323OPCS193804

Test Report Status Final Results Biological Reference Interval Units

BIOCHEMISTRY
GLYCOSYLATED HEMOGLOBIN(HBA1C), EDTA WHOLE BLOOD
HBA1C 7.7 High Non-diabetic Adult < 5.7 %
Pre-diabetes 5.7 - 6.4
Diabetes diagnosis: > or = 6.5
Therapeutic goals: < 7.0
Action suggested : > 8.0
(ADA Guideline 2021)
METHOD : HPLC

ESTIMATED AVERAGE GLUCOSE(EAG) 174.3 High < 116.0 mg/dL

SODIUM, SERUM
SODIUM, SERUM 136 136 - 145 mmol/L
CREATININE EGFR- EPI
CREATININE 1.16 0.80 - 1.30 mg/dL
AGE 83 years
GLOMERULAR FILTRATION RATE (MALE) 62.50 Refer Interpretation Below mL/min/1.73m2

Interpretation(s)
GLYCOSYLATED HEMOGLOBIN(HBA1C), EDTA WHOLE BLOOD-Used For:

1. Evaluating the long-term control of blood glucose concentrations in diabetic patients.

2. Diagnosing diabetes.
3. Identifying patients at increased risk for diabetes (prediabetes).
The ADA recommends measurement of HbA1c (typically 3-4 times per year for type 1 and poorly controlled type 2 diabetic patients, and 2 times per year for
well-controlled type 2 diabetic patients) to determine whether a patients metabolic control has remained continuously within the target range.
1. eAG (Estimated average glucose) converts percentage HbA1c to md/dl, to compare blood glucose levels.
2. eAG gives an evaluation of blood glucose levels for the last couple of months.
3. eAG is calculated as eAG (mg/dl) = 28.7 * HbA1c - 46.7

HbA1c Estimation can get affected due to :

1. Shortened Erythrocyte survival : Any condition that shortens erythrocyte survival or decreases mean erythrocyte age (e.g. recovery from acute blood loss,hemolytic
anemia) will falsely lower HbA1c test results.Fructosamine is recommended in these patients which indicates diabetes control over 15 days.
2.Vitamin C & E are reported to falsely lower test results.(possibly by inhibiting glycation of hemoglobin.
3. Iron deficiency anemia is reported to increase test results. Hypertriglyceridemia,uremia, hyperbilirubinemia, chronic alcoholism,chronic ingestion of salicylates & opiates
addiction are reported to interfere with some assay methods,falsely increasing results.
4. Interference of hemoglobinopathies in HbA1c estimation is seen in

a) Homozygous hemoglobinopathy. Fructosamine is recommended for testing of HbA1c.

b) Heterozygous state detected (D10 is corrected for HbS & HbC trait.)
c) HbF > 25% on alternate paltform (Boronate affinity chromatography) is recommended for testing of HbA1c.Abnormal Hemoglobin electrophoresis (HPLC method) is
recommended for detecting a hemoglobinopathy
SODIUM, SERUM-Increased in dehydration,

Page 1 Of 7

Dr. Prajwal A, MD Dr.Suneet Kaur Hora

CONSULTANT BIOCHEMIST LAB HEAD & Sr. CONSULTANT
(SECTION HEAD) PATHOLOGIST

View Details View Report

PERFORMED AT :
Agilus Diagnostics Ltd.
154/9, Bannerghatta Road, Opp. Iim-B,
Bangalore, 560076 Patient Ref. No. 81000002499135
Karnataka, India
Tel : 80-66214444, Fax :
CIN - U74899PB1995PLC045956
 DIAGNOSTIC REPORT

MC -5767

PATIENT NAME : SUNDARAM ANNASWAMY REF. DOCTOR : DR. Srinivasa Phanidhar Munigoti
CODE/NAME & ADDRESS : C000027810 ACCESSION NO : 0081WH000271 AGE/SEX : 83 Years Male
FHSL BG ROAD - OPD PATIENT ID : FH.4937401 DRAWN : 01/08/2023 10:30:00
SURVEY NO. 154/9, OPP. IIM-B,BANNERGHATTA
CLIENT PATIENT ID: UID:4937401 RECEIVED : 01/08/2023 10:30:27
ROAD,
ABHA NO : REPORTED : 01/08/2023 11:50:56
BANGALORE 560020
80-66214444

CLINICAL INFORMATION :

UID:4937401 REQNO-6146834
OPD-OPD
BILLNO-111323OPCS193804

Test Report Status Final Results Biological Reference Interval Units

cushing'''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''
syndrome, aldosteronism Decreased in
Addison''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''''
disease, hypopituitarism,liver disease.
CREATININE EGFR- EPI-GFR— Glomerular filtration rate (GFR) is a measure of the function of the kidneys. The GFR is a calculation based on a serum creatinine test.
Creatinine is a muscle waste product that is filtered from the blood by the kidneys and excreted into urine at a relatively steady rate. When kidney function decreases, less
creatinine is excreted and concentrations increase in the blood. With the creatinine test, a reasonable estimate of the actual GFR can be determined.
A GFR of 60 or higher is in the normal range.
A GFR below 60 may mean kidney disease.
A GFR of 15 or lower may mean kidney failure.
Estimated GFR (eGFR) is the preferred method for identifying people with chronic kidney disease (CKD). In adults, eGFR calculated using the Modification of Diet in Renal
Disease (MDRD) Study equation provides a more clinically useful measure of kidney function than serum creatinine alone.
The CKD-EPI creatinine equation is based on the same four variables as the MDRD Study equation, but uses a 2-slope spline to model the relationship between estimated
GFR and serum creatinine, and a different relationship for age, sex and race. The equation was reported to perform better and with less bias than the MDRD Study equation,
especially in patients with higher GFR. This results in reduced misclassification of CKD.
The CKD-EPI creatinine equation has not been validated in children & will only be reported for patients = 18 years of age. For pediatric and childrens, Schwartz Pediatric
Bedside eGFR (2009) formulae is used. This revised "bedside" pediatric eGFR requires only serum creatinine and height.

Page 2 Of 7

Dr. Prajwal A, MD Dr.Suneet Kaur Hora

CONSULTANT BIOCHEMIST LAB HEAD & Sr. CONSULTANT
(SECTION HEAD) PATHOLOGIST

View Details View Report

PERFORMED AT :
Agilus Diagnostics Ltd.
154/9, Bannerghatta Road, Opp. Iim-B,
Bangalore, 560076 Patient Ref. No. 81000002499135
Karnataka, India
Tel : 80-66214444, Fax :
CIN - U74899PB1995PLC045956
 DIAGNOSTIC REPORT

MC -5767

PATIENT NAME : SUNDARAM ANNASWAMY REF. DOCTOR : DR. Srinivasa Phanidhar Munigoti
CODE/NAME & ADDRESS : C000027810 ACCESSION NO : 0081WH000271 AGE/SEX : 83 Years Male
FHSL BG ROAD - OPD PATIENT ID : FH.4937401 DRAWN : 01/08/2023 10:30:00
SURVEY NO. 154/9, OPP. IIM-B,BANNERGHATTA
CLIENT PATIENT ID: UID:4937401 RECEIVED : 01/08/2023 10:30:27
ROAD,
ABHA NO : REPORTED : 01/08/2023 11:50:56
BANGALORE 560020
80-66214444

CLINICAL INFORMATION :

UID:4937401 REQNO-6146834
OPD-OPD
BILLNO-111323OPCS193804

Test Report Status Final Results Biological Reference Interval Units

BIOCHEMISTRY - LIPID
LIPID PROFILE, SERUM
CHOLESTEROL, TOTAL 195 Desirable : < 200 mg/dL
Borderline : 200 - 239
High : > / = 240
TRIGLYCERIDES 184 High Normal: < 150 mg/dL
Borderline high: 150 - 199
High: 200 - 499
Very High: >/= 500
HDL CHOLESTEROL 45 At Risk: < 40 mg/dL
Desirable: > or = 60
LDL CHOLESTEROL, DIRECT 136 High Optimal : < 100 mg/dL
Near/Above Optimal :100 - 129
Borderline High : 130 - 159
High : 160 - 189
Very High : > / = 190
NON HDL CHOLESTEROL 150 High Desirable : < 130 mg/dL
Above Desirable : 130 -159
Borderline High : 160 - 189
High : 190 - 219
Very high : > / = 220
VERY LOW DENSITY LIPOPROTEIN 36.8 High < or = 30.0 mg/dL
CHOL/HDL RATIO 4.3 Low Risk : 3.3 - 4.4
Average Risk : 4.5 - 7.0
Moderate Risk : 7.1 - 11.0
High Risk : > 11.0
LDL/HDL RATIO 3.0 Desirable/Low Risk: 0.5 - 3.0
Borderline/Moderate :3.1-6.0
High Risk : > 6.0
Interpretation(s)

Page 3 Of 7

Dr.Suneet Kaur Hora Dr. Prajwal A, MD

LAB HEAD & Sr. CONSULTANT CONSULTANT BIOCHEMIST
PATHOLOGIST (SECTION HEAD)

View Details View Report

PERFORMED AT :
Agilus Diagnostics Ltd.
154/9, Bannerghatta Road, Opp. Iim-B,
Bangalore, 560076 Patient Ref. No. 81000002499135
Karnataka, India
Tel : 80-66214444, Fax :
CIN - U74899PB1995PLC045956
 DIAGNOSTIC REPORT

MC -5767

PATIENT NAME : SUNDARAM ANNASWAMY REF. DOCTOR : DR. Srinivasa Phanidhar Munigoti
CODE/NAME & ADDRESS : C000027810 ACCESSION NO : 0081WH000271 AGE/SEX : 83 Years Male
FHSL BG ROAD - OPD PATIENT ID : FH.4937401 DRAWN : 01/08/2023 10:30:00
SURVEY NO. 154/9, OPP. IIM-B,BANNERGHATTA
CLIENT PATIENT ID: UID:4937401 RECEIVED : 01/08/2023 10:30:27
ROAD,
ABHA NO : REPORTED : 01/08/2023 11:50:56
BANGALORE 560020
80-66214444

CLINICAL INFORMATION :

UID:4937401 REQNO-6146834
OPD-OPD
BILLNO-111323OPCS193804

Test Report Status Final Results Biological Reference Interval Units

Page 4 Of 7

Dr.Suneet Kaur Hora Dr. Prajwal A, MD

LAB HEAD & Sr. CONSULTANT CONSULTANT BIOCHEMIST
PATHOLOGIST (SECTION HEAD)

View Details View Report

PERFORMED AT :
Agilus Diagnostics Ltd.
154/9, Bannerghatta Road, Opp. Iim-B,
Bangalore, 560076 Patient Ref. No. 81000002499135
Karnataka, India
Tel : 80-66214444, Fax :
CIN - U74899PB1995PLC045956
 DIAGNOSTIC REPORT

MC -5767

PATIENT NAME : SUNDARAM ANNASWAMY REF. DOCTOR : DR. Srinivasa Phanidhar Munigoti
CODE/NAME & ADDRESS : C000027810 ACCESSION NO : 0081WH000271 AGE/SEX : 83 Years Male
FHSL BG ROAD - OPD PATIENT ID : FH.4937401 DRAWN : 01/08/2023 10:30:00
SURVEY NO. 154/9, OPP. IIM-B,BANNERGHATTA
CLIENT PATIENT ID: UID:4937401 RECEIVED : 01/08/2023 10:30:27
ROAD,
ABHA NO : REPORTED : 01/08/2023 11:50:56
BANGALORE 560020
80-66214444

CLINICAL INFORMATION :

UID:4937401 REQNO-6146834
OPD-OPD
BILLNO-111323OPCS193804

Test Report Status Final Results Biological Reference Interval Units

Page 5 Of 7

Dr.Suneet Kaur Hora Dr. Prajwal A, MD

LAB HEAD & Sr. CONSULTANT CONSULTANT BIOCHEMIST
PATHOLOGIST (SECTION HEAD)

View Details View Report

PERFORMED AT :
Agilus Diagnostics Ltd.
154/9, Bannerghatta Road, Opp. Iim-B,
Bangalore, 560076 Patient Ref. No. 81000002499135
Karnataka, India
Tel : 80-66214444, Fax :
CIN - U74899PB1995PLC045956
 DIAGNOSTIC REPORT

MC -5767

PATIENT NAME : SUNDARAM ANNASWAMY REF. DOCTOR : DR. Srinivasa Phanidhar Munigoti
CODE/NAME & ADDRESS : C000027810 ACCESSION NO : 0081WH000271 AGE/SEX : 83 Years Male
FHSL BG ROAD - OPD PATIENT ID : FH.4937401 DRAWN : 01/08/2023 10:30:00
SURVEY NO. 154/9, OPP. IIM-B,BANNERGHATTA
CLIENT PATIENT ID: UID:4937401 RECEIVED : 01/08/2023 10:30:27
ROAD,
ABHA NO : REPORTED : 01/08/2023 11:50:56
BANGALORE 560020
80-66214444

CLINICAL INFORMATION :

UID:4937401 REQNO-6146834
OPD-OPD
BILLNO-111323OPCS193804

Test Report Status Final Results Biological Reference Interval Units

SPECIALISED CHEMISTRY - HORMONE

FREE THYROXINE (FT4), SERUM
FREE THYROXINE (FT4) 1.60 0.93 - 1.71 ng/dL
TSH 3RD GENERATION ULTRASENSITIVE, SERUM
TSH (ULTRASENSITIVE) 0.029 Low 0.270 - 4.200 µIU/mL

Interpretation(s)
FREE THYROXINE (FT4), SERUM-Thyroxine(T4)circulates in the blood as an equilibrium mixture of free and serum protein bound hormone. Less than 0.03% is present in the
circulation as unbound, free T4. This small percentage of the total T4 represents the physiologically available hormone which is biologically active.
Free T3 and Free T4 values therefore, provide the best indication of thyroid dysfunction, instead of Total T3 or Total T4, since these are not affected by changes in the
serum binding proteins. Free T3 is typically elevated to a greater degree than free thyroxine (T4) in Graves’ disease.
Occasionally, free T3 alone is elevated (T3 thyrotoxicosis) in about 5% of the hyperthyroid population. In contrast, levels of free T4 are elevated to a greater degree than
free T3 in toxic multinodular goiter and excessive T4 therapy. Serum free T3 is useful in distinguishing these forms of hyperthyroidism.
Free T3 may also be important in monitoring patients on anti-thyroid therapy where treatment is focused on reducing the T3 production and the T4 conversion to T3. Serum
free T3 may also be useful in assessing the severity of the thyrotoxic state.
TSH 3RD GENERATION ULTRASENSITIVE, SERUM-TSH stands for thyroid stimulating hormone.This hormone stimulates the Thyroid gland to make thyroid hormones
that regulate the way our body uses energy. These also play an important role in regulating weight, temperature, muscle strength, and even your mood. TSH is made in a
gland in the brain called the pituitary. When thyroid levels in our body are low, the pituitary gland makes more TSH. When thyroid levels are high, the pituitary gland makes
less TSH. TSH levels that are too high or too low can indicate that thyroid is not working correctly.
There is a circadian rhythm of TSH secretion, with peak values at the onset of sleep and nadir concentrations during the afternoon hours. Peak and nadir concentrations
differ by approximately +/- 50%. The effect on circulating T4 and T3 concentrations is not significant because of the large size of the extrathyroidal T4 pool.
In healthy subjects there is no significant impact of body weight, physical training, body habitus, posture, immobilization, mild to moderate exercise, or ambulatory status
on thyroid function, and no significant geographic environmental variation. Nutrition also has a minimal impact except for variation in iodine intake. Subthreshold
concentrations of iodine intake are associated with increased TSH secretion, goiter, increased thyroid iodine uptake, decreased T4 production, an increased T3/T4 secretion
ratio, and an increased ratio of circulating T3/T4 concentrations. Excessive iodine intake can block thyroid hormone biosynthesis by inhibiting the enzymes involved in the
biosynthetic process, resulting in reduced T4 secretion, increased TSH concentrations, goiter, and hypothyroidism if the iodine excess is chronic.
High TSH levels can mean your thyroid is not making enough thyroid hormones, a condition called hypothyroidism.Low TSH levels can mean your thyroid is making too
much of the hormones, a condition called hyperthyroidism. A TSH test does not explain why TSH levels are too high or too low.
In cases of Subclinical hypothyroidism, a single test can be misleading, so a second test is usually done 2 or 3 months later. In both tests, the blood is taken at the same
time of day because TSH levels can fluctuate over the course of 24 hours. Subclinical hypothyroidism is diagnosed when both TSH readings are high but the thyroid
hormone thyroxine is still within the normal range.
Being severely overweight and certain medications can also increase TSH. TSH levels are likely to fluctuate more during pregnancy.
TSH values may be transiently altered because of Non thyroidal Illness like severe infections, liver disease, renal failure, heart failure, severe burns, trauma, surgery etc.
TSH levels that are slightly or only moderately elevated do not necessarily need to be treated. Some people who have high TSH levels never even develop symptoms.
It is also very common for TSH levels to return to normal in children and teenagers.
REF: 1. TIETZ Fundamentals of Clinical chemistry 2Guidlines of the American Thyroid association during pregnancy and Postpartum,2011.

**End Of Report**
Please visit www.agilusdiagnostics.com for related Test Information for this accession

Page 6 Of 7

Dr. Prajwal A, MD
CONSULTANT BIOCHEMIST
(SECTION HEAD)

View Details View Report

PERFORMED AT :
Agilus Diagnostics Ltd.
154/9, Bannerghatta Road, Opp. Iim-B,
Bangalore, 560076 Patient Ref. No. 81000002499135
Karnataka, India
Tel : 80-66214444, Fax :
CIN - U74899PB1995PLC045956
 DIAGNOSTIC REPORT

MC -5767

PATIENT NAME : SUNDARAM ANNASWAMY REF. DOCTOR : DR. Srinivasa Phanidhar Munigoti
CODE/NAME & ADDRESS : C000027810 ACCESSION NO : 0081WH000271 AGE/SEX : 83 Years Male
FHSL BG ROAD - OPD PATIENT ID : FH.4937401 DRAWN : 01/08/2023 10:30:00
SURVEY NO. 154/9, OPP. IIM-B,BANNERGHATTA
CLIENT PATIENT ID: UID:4937401 RECEIVED : 01/08/2023 10:30:27
ROAD,
ABHA NO : REPORTED : 01/08/2023 11:50:56
BANGALORE 560020
80-66214444

CLINICAL INFORMATION :

UID:4937401 REQNO-6146834
OPD-OPD
BILLNO-111323OPCS193804

Test Report Status Final Results Biological Reference Interval Units

CONDITIONS OF LABORATORY TESTING & REPORTING

1. It is presumed that the test sample belongs to the patient 5. Agilus confirms that all tests have been performed or
named or identified in the test requisition form. assayed with highest quality standards, clinical safety &
2. All Tests are performed and reported as per the technical integrity.
turnaround time stated in the Agilus Directory of services 6. Laboratory results should not be interpreted in isolation;
(DOS). it must be correlated with clinical information and be
3. Agilus Diagnostics confirms that all tests have been interpreted by registered medical practitioners only to
performed or assayed with highest quality standards, clinical determine final diagnosis.
safety & technical integrity. 7. Test results may vary based on time of collection,
4. A requested test might not be performed if: physiological condition of the patient, current medication or
a. Specimen received is insufficient or inappropriate nutritional and dietary changes. Please consult your doctor
specimen quality is unsatisfactory or call us for any clarification.
b. Incorrect specimen type 8. Test results cannot be used for Medico legal purposes.
c. Request for testing is withdrawn by the ordering doctor 9. In case of queries please call customer care
or patient (91115 91115) within 48 hours of the report.
d. There is a discrepancy between the label on the .
specimen container and the name on the test requisition
form
Agilus Diagnostics Ltd
Fortis Hospital, Sector 62, Phase VIII,
Mohali 160062

Page 7 Of 7

Dr. Prajwal A, MD
CONSULTANT BIOCHEMIST
(SECTION HEAD)

View Details View Report

PERFORMED AT :
Agilus Diagnostics Ltd.
154/9, Bannerghatta Road, Opp. Iim-B,
Bangalore, 560076 Patient Ref. No. 81000002499135
Karnataka, India
Tel : 80-66214444, Fax :
CIN - U74899PB1995PLC045956